![Brian Kotzin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Kotzin
Net worth: 833 427 $ as of 30/12/2025
Profile
Brian L.
Kotzin currently works at Benaroya Research Institute at Virginia Mason, as Director, Biora Therapeutics, Inc., as Independent Director from 2019, argenx SE, as Non-Executive Director from 2024, Genascence Corp., as Director from 2022, Nektar Therapeutics, as Chief Medical Officer from 2023, Association of American Physicians, as Member, and American Society of Clinical Investigation, as Member.
Dr. Kotzin also formerly worked at National Institues of Health, as Chairman-Immunological Sciences Study Section, American College of Rheumatology, as Director, Federation of Clinical Immunology Societies, as Director, Vera Therapeutics, Inc., as Director, Autoimmunity Center of Excellence, as Director & Head-Clinical Immunology from 1998 to 2004, the University of Colorado Health Sciences Center, as Director-Autoimmunity Centre of Excellence from 1981 to 2004, Kyverna Therapeutics, Inc., as Independent Director from 2019 to 2024, Rigel Pharmaceuticals, Inc., as Independent Director from 2017 to 2024, Amgen, Inc., as VP-Global Clinical Development & Head-Inflammation, Veterans Administration Medical Center, as Chief-Rheumatology Section, and National Jewish Health, Inc., as Professor.
Dr. Kotzin received his undergraduate degree from the University of Southern California and doctorate degree from Stanford University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/09/2025 | 990 ( 0% ) | 833 427 $ | 30/12/2025 | |
| 29/09/2024 | 182 ( 0% ) | - $ | 30/12/2025 |
Brian Kotzin active positions
| Companies | Position | Start |
|---|---|---|
| NEKTAR THERAPEUTICS | Chief Tech/Sci/R&D Officer | 31/03/2022 |
| BIORA THERAPEUTICS, INC. | Director/Board Member | 31/05/2019 |
| ARGENX SE | Director/Board Member | 06/05/2024 |
Genascence Corp.
 Genascence Corp. Operates as a clinical-stage biotechnology company developing gene therapy products for prevalent musculoskeletal diseases | Director/Board Member | 31/12/2021 |
Association of American Physicians
 Association of American Physicians Miscellaneous Commercial ServicesCommercial Services Operates American association of physicians | Corporate Officer/Principal | - |
American Society of Clinical Investigation | Corporate Officer/Principal | - |
Benaroya Research Institute at Virginia Mason
 Benaroya Research Institute at Virginia Mason Miscellaneous Commercial ServicesCommercial Services Operates medical research institute for autoimmune and immune system diseases | Director/Board Member | - |
Former positions of Brian Kotzin
| Companies | Position | End |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Director/Board Member | 15/09/2024 |
| KYVERNA THERAPEUTICS, INC. | Director/Board Member | 12/09/2024 |
| ░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Brian Kotzin
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Amgen, Inc.
 Amgen, Inc. Discovers, develops, manufactures and delivers human therapeutics | |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Rigel Pharmaceuticals, Inc.
 Rigel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which discovers, develops and provides novel small-molecule drugs | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Health Sciences Center
 University of Colorado Health Sciences Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Veterans Administration Medical Center
 Veterans Administration Medical Center Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Association of American Physicians
Association of American Physicians Miscellaneous Commercial ServicesCommercial Services Operates American association of physicians | Commercial Services |
American Society of Clinical Investigation | |
American College of Rheumatology
 American College of Rheumatology Miscellaneous Commercial ServicesCommercial Services Operates as an organization for physicians and health professionals | Commercial Services |
argenx SE
 argenx SE BiotechnologyHealth Technology Develops therapies and medicines for the treatment of autoimmune diseases | Health Technology |
Benaroya Research Institute at Virginia Mason
Benaroya Research Institute at Virginia Mason Miscellaneous Commercial ServicesCommercial Services Operates medical research institute for autoimmune and immune system diseases | Commercial Services |
National Jewish Health, Inc.
 National Jewish Health, Inc. Provides treatment of and conducts research in respiratory, immune and allergic disorders | |
Federation of Clinical Immunology Societies
 Federation of Clinical Immunology Societies The Federation of Clinical Immunology Societies (FOCIS) improves human health through immunology by fostering interdisciplinary approaches to understand and treat immune-based diseases. FOCIS was initially established as a cross-disciplinary meeting and held its first Annual Meeting in 2003. It incorporated as a 501(c)3 organization in the same year. FOCIS serves as a key forum for opinion leaders to collaborate and chart the path to the next major breakthrough in disease therapy. It is composed of 58 Member Societies representing approximately 65,000 clinician scientists. The company is based in Milwaukee, WI. | |
Stanford University School of Medicine
 Stanford University School of Medicine Functions as a College/University | |
Biora Therapeutics, Inc.
 Biora Therapeutics, Inc. Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases | |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | |
Genascence Corp.
Genascence Corp. Operates as a clinical-stage biotechnology company developing gene therapy products for prevalent musculoskeletal diseases | |
Autoimmunity Center of Excellence |
- Stock Market
- Insiders
- Brian Kotzin
